Financial Performance - Revenue decreased by 8.7% from RMB 407.1 million for the year ended December 31, 2024, to RMB 371.6 million for the year ended December 31, 2025[4] - Net profit decreased by 19.0% from RMB 62.5 million for the year ended December 31, 2024, to RMB 50.6 million for the year ended December 31, 2025[4] - Adjusted net profit (non-IFRS measure) decreased by 11.1% from RMB 68.3 million for the year ended December 31, 2024, to RMB 60.7 million for the year ended December 31, 2025[4] - Total revenue for 2025 was RMB 371,571 thousand, a decrease of 8.7% from RMB 407,083 thousand in 2024[11] - Revenue from orthodontic services in 2025 was RMB 70,643 thousand, down 4.0% from RMB 74,115 thousand in 2024[11] - Revenue from dental implant services decreased by 14.9% to RMB 98,400 thousand in 2025 from RMB 115,647 thousand in 2024[11] - Comprehensive dental treatment services revenue fell to RMB 202,528 thousand, a decline of 6.8% from RMB 217,321 thousand in 2024[11] - Pre-tax profit for 2025 was RMB 28,175 thousand, down 32.8% from RMB 41,916 thousand in 2024[21] - Gross profit decreased by 8.0% from RMB 152.3 million to RMB 140.1 million, while gross margin increased from 37.4% to 37.7% due to effective cost control[48] - Net profit decreased by 19.0% from RMB 62.5 million to RMB 50.6 million, with net profit margin declining from 15.4% to 13.6%[53] Operational Highlights - The number of patient visits reached 729,404, with 159,535 new patient visits during the year ended December 31, 2025[4] - The company opened 8 new dental clinics and 2 dental offices during the year ended December 31, 2025[4] - The company operates a growing dental service network under the unified brand "Aishang Dazhong Dental" in Hubei and Hunan provinces[24] - The company opened 8 new dental clinics and 2 dental offices in 2025, bringing the total to 92 dental medical institutions, including 4 hospitals, 80 clinics, and 8 offices[25] - As of December 31, 2025, 54.8% of dentists held intermediate or higher professional titles, ensuring high-quality medical services[34] - The company has a total of 1,015 employees, with 932 (92%) working in dental medical institutions[33] Financial Position - Total assets minus current liabilities increased from RMB 242.9 million in 2024 to RMB 424.0 million in 2025[6] - Cash and deposits increased significantly from RMB 95.0 million in 2024 to RMB 251.5 million in 2025[6] - Total liabilities decreased from RMB 218.98 million in 2024 to RMB 140.71 million in 2025[7] - Net assets increased from RMB 159.01 million in 2024 to RMB 374.27 million in 2025[7] - Trade receivables increased to RMB 7,415 thousand in 2025 from RMB 5,836 thousand in 2024[22] - Trade payables decreased to RMB 9,778 thousand in 2025 from RMB 14,678 thousand in 2024[23] - The current ratio improved to 3.4 times as of December 31, 2025, compared to 0.9 times as of December 31, 2024[58] - Cash and deposits increased from RMB 95.0 million as of December 31, 2024, to RMB 251.5 million as of December 31, 2025, primarily due to increased funds raised from the listing[58] Dividend and Shareholder Information - Proposed final dividend of RMB 0.668 per share (tax included) for the year ended December 31, 2025[4] - The company proposed a final dividend of RMB 0.668 per share, totaling RMB 32,985 thousand, pending shareholder approval[19] - The board proposed a final dividend of RMB 0.668 per share, totaling RMB 32,985,200, subject to shareholder approval at the 2025 annual general meeting[71] - The proposed final dividend is expected to be distributed no later than June 30, 2026, contingent upon shareholder approval[71] - The 2025 annual general meeting is scheduled for May 29, 2026, with relevant documents to be sent to shareholders[75] - Share transfer registration will be suspended from May 26 to May 29, 2026, to determine the list of shareholders eligible to attend and vote at the annual general meeting[76] - A similar suspension of share transfer registration will occur from June 4 to June 5, 2026, to determine shareholders eligible for the proposed final dividend[77] - The annual report for the year ending December 31, 2025, will be sent to shareholders and published on the company's and the stock exchange's websites[78] Strategic Outlook - The company aims to enhance operational efficiency and profitability in the central China market, focusing on fine-tuned operations and cost control[37] - The company plans to pursue high-quality expansion through strategic acquisitions and self-built facilities, emphasizing investment returns[38] - The Chinese dental medical service market is projected to reach RMB 200.4 billion by 2029, driven by increasing health management awareness and demographic changes[35] - The central China region is expected to see dental service demand continue to grow, outpacing the national average growth rate[36] - The company is committed to a market strategy that focuses on Wuhan, covering Hubei and radiating throughout central China[37] Cost Management and Efficiency - Administrative expenses decreased by 16.3% from RMB 34.9 million to RMB 29.2 million, primarily due to optimization of functional and personnel structure[51] - Sales and distribution expenses increased by 4.8% from RMB 40.5 million to RMB 42.4 million, mainly due to increased advertising and promotional expenses[50] - Cost management strategies resulted in a 5% reduction in operational expenses, improving overall profitability[84] Market Performance - The company reported a revenue increase of 15% year-over-year, reaching RMB 5 billion in Q3 2023[84] - User data showed a growth of 20% in active users, totaling 10 million by the end of the quarter[84] - The company provided a forward guidance of 10% revenue growth for the next quarter, projecting RMB 5.5 billion[84] - New product launches contributed to a 25% increase in sales, with three new products introduced in the last quarter[84] - Market expansion efforts have led to a 30% increase in market share in Southeast Asia[84] - The company completed a strategic acquisition of a competitor for RMB 1 billion, expected to enhance its product offerings[84] - The company plans to enter the European market by Q2 2024, targeting a revenue contribution of RMB 500 million[84] - Customer satisfaction ratings improved by 15%, reflecting the success of recent service enhancements[84]
大众口腔(02651) - 2025 - 年度业绩